TECX
Tectonic Therapeutic, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Alise S. Reicin
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Tectonic Therapeutic, Inc.
CEO
Alise S. Reicin
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 172 |
| $35.00 |
| 1 Jul 2026 | McNamara Peter | Chief Scientific Officer | M-Exempt | Disposed | 172 | $14.71 |
| 23 Jun 2026 | REICIN ALISE | director, officer: Chief Executive Officer | F-InKind | Disposed | 924 | $30.34 |
| 12 Jun 2026 | Lochner Daniel | Chief Financial Officer | A-Award | Acquired | 7,500 | $16.80 |
| 10 Jun 2026 | SPRINGER TIMOTHY A | director, 10 percent owner: | A-Award | Acquired | 10,200 | $28.56 |
| 10 Jun 2026 | Tipirneni Praveen P. | director | A-Award | Acquired | 10,200 | $28.56 |
| 10 Jun 2026 | Donenberg Phillip B. | director | A-Award | Acquired | 10,200 | $28.56 |
| 10 Jun 2026 | Vitorovic Stefan | director | A-Award | Acquired | 10,200 | $28.56 |
| 10 Jun 2026 | Chutter Jessica Caroline | director | A-Award | Acquired | 20,400 | $29.10 |